Updated clinical results of BT-001, an oncolytic virus expressing an anti-CTLA4 mAb,administered in combination with pembrolizumab in patients with advanced solid tumorsC. Lebbe, et al. ESMO 2025 Abstract available on ESMO website – Download the abstract – Download the Poster